Temporal alterations in basement membrane components in the pulmonary vasculature of the chronically hypoxic rat: Impact of hypoxia and recovery

American Journal of the Medical Sciences

Volumn 312, Issue 2, 1996, Pages 54-67

  Vyas Somani, Anjili C ^a   Aziz, Shewan M ^a,c   Arcot, Santosh A ^b   Gillespie, Mark N ^a   Olson, Jack W ^a   Lipke, David W ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^c University of Kentucky   (United States)

Author keywords

Fibronectin; Laminin; Pulmonary Hypertension; Type IV Collagen

Indexed keywords

COLLAGEN TYPE 4; FIBRONECTIN; GLYCOPROTEIN; LAMININ; MESSENGER RNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CONTROLLED STUDY; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG HEMODYNAMICS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; RAT;

EID: 0029789551     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-199608000-00002     Document Type: Article

References (46)

1. Lai YI, Olson JW, Gillespie MN. Ventilatory disfunction precedes pulmonary vascular changes in monocrotaline-treated rats. J Appl Physiol. 1991;70:561-66.
2. Morgan JM, Griffiths M, du Bois RM, Evans TW. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest. 1991;99:551-56.
3. Rabinovitch M, Gamble W, Nadas AS, Miettinen OS, Reid LM. Rat pulmonary circulation after chronic hypoxia: Hemodynamic and structural features. Am J Physiol. 1979;236:H818-H827.
4. Reeves JT, Groves BM. Approach to the patient with pulmonary hypertension. In: Weir, Reeves; eds. Pulmonary hypertension. New York: Futura Publishing Company, Inc.; 1984.
5. Wagenvoort CA, Wagenvoort N. Pathology of Pulmonary Hypertension. New York: John Wiley & Sons; 1977.
6. Martinez-Hernandez A. Repair, regeneration, and fibrosis. In: Rubin E, Farber JL; eds. Pathology. Philadelphia: Lippincott-Raven; 1988.
7. Sobin SS, Tremer HM, Hardy JD, Chiodi HP. Changes in arterioles in acute and chronic hypoxic pulmonary hypertension. J Appl Physiol. 1983;55:1445-55.
8. Todorovitch-Hunter L, Johnson DJ, Ranger P, Keely FW, Rabinovitch M. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. Lab Invest. 1988;58:184-95.
9. Tozzi CA, Poiani GJ, Edelman NH, Riley DJ. Vascular collagen affects reactivity of hypertensive pulmonary arteries of the rat. J Appl Physiol. 1989;66:1730-35.
10. Lipke DW, Arcot SS, Olson J, Temporal alterations in specific basement membrane components in lungs from monocrotaline-treated rats. Am J Respir Cell Mol Biol. 1993;9:418-28.
11. Botney MD, Kaiser LR, Cooper JD, Mecham RP, Parghi D, Roby J, et al. Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am J Pathol. 1992;140:357-64.
12. Lipke DW, McCarthy KJ, Elton TS, Arcot SS, Oparil S, Couchman JR. Coarctation induces alterations in basement membranes in the cardiovascular system. Hypertension. 1993;22:743-53.
13. Takasaki I, Chobanian AV, Sarzani R, Brecher P. Effect of hypertension on fibronectin expression in the rat aorta. J Biol Chem. 1990;265:21935-39.
14. Takasaki I, Chobanian AV, Brecher P. Biosynthesis of fibronectin by rabbit aorta. J Biol Chem. 1991;266:17686-94.
15. Takasaki I, Chobanian AV, Mamuya WS, Brecher P. Hypertension induces alternatively spliced forms of fibronectin in rat aorta. Hypertension. 1992;20:20-25.
16. Guyton JR, Dao DT, Lindsay KL, Taylor AA. Ultrastructure of hypertensive rat aorta: increased basement membrane-like material. Hypertension. 1990;15:56-67.
17. McGuire PG, Brocks DG, Killen PD, Orkin RW. Increased deposition of basement membrane macromolecules in specific vessels of the spontaneously hypertensive rat. Am J Pathol. 1989;135:291-99.
18. Penaloza D, Sime F, Banchero N, Gamboa R. Pulmonary hypertension in healthy man born and living at high altitudes. Medicina Thoracalis. 1962;19:449-60.
19. Abraham AS, Cole RB, Bishop JM. Reversal of pulmonary hypertension by prolonged oxygen administration to patients with chronic bronchitis. Circ Res. 1968;23:147-57.
20. Levine BE, Bigelow DB, Hamstra RD, Beckwitt HJ, Mitchell RS, Nett LM, et al. The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxemia. Ann Intern Med. 1967;66:639-50.
21. Alexander AF, Will DH, Wolff W. Pulmonary vascular alterations during recovery from bovine high mountain disease. Am J Vet Res. 1965;26:1042-46.
22. Heath D, Edwards C, Winson M, Smith P. Effects on the right ventricle, pulmonary vasculature, and carotid bodies of the rat of exposure to, and recovery from, simulated high altitude. Thorax. 1973;28:24-28.
23. Hislop A, Reid LM. Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats. British Journal of Experimental Pathology. 1974;55:155-63.
24. Folkvord JM, Viders D, Coleman-Smith A, Clark RAF. Optimization of immunohistochemical techniques to detect extracellular matrix proteins in fixed skin specimens. J Histochem Cytochem. 1989;37:105-13.
25. Couchman JR, Austria MR, Woods A. Fibronectin-cell interactions. J Invest Dermatol. 1990;94(suppl):7S-14S.
26. Claycomb WC, Lanson NA. Proto-oncogene expression in proliferating and differentiating cardiac and skeletal muscle. Biochem J. 1987;247:701-06.
27. Sasaki M, Yamada Y. The laminin B2 chain has a multidomain structure homologous to the B1 chain. J Biol Chem. 1987;262:17111-17.
28. Nath P, Laurent M, Horn E, Sobe ME, Zon G, Vogeli G. Isolation of an alpha 1 type IV collagen cDNA clone using a synthetic oligodeoxynucleotide. Gene. 1986;43:301-04.
29. Hunter C, Barer G, Shaw J, Clegg E. Growth of the heart and lungs in hypoxic rodents: A model of human hypoxic disease. Clinical Science and Molecular Medicine. 1974;46:375-91.
30. Smith P, Moosavi H, Winson H, Heath D. The influence of age and sex on the response of the right ventricle, pulmonary vasculature and carotid bodies to hypoxia in rats. J Pathol. 1974;112:11-18.
31. Tucker A, McMurtry IF, Reeves JT, Alexander AF, Will DH, Grover RF. Lung vascular smooth muscle as a determinant of pulmonary hypertension at high altitude. Am J Physiol. 1975;228:762-67.
32. Barer GR, Howard P, Shaw JW. Stimulus-response curves for the pulmonary vascular bed to hypoxia and hypercapnia. J Physiol (Lond). 1970;211:139-55.
33. Fishman AP. Pulmonary circulation. In: Fishman AP, Fisher AB; eds. Handbook of Physiology: The Respiratory System. Vol. I. Bethesda, MD: American Physiological Society; 1985:93-165.
34. Hynes RO. Molecular biology of fibronectin. Annu Rev Cell Biol. 1985;1:67-90.
35. Tozzi CA, Wilson FJ, Yu SY, Bannett RF, Peng PW, Riley DJ. Vascular connective tissue is rapidly degraded during early regression of pulmonary hypertension. Chest. 1991;99(suppl): 41S-42S.
36. Albelda SM, Buck CA. Intergrins and other cell adhesion molecules. FASEB J. 1990;4:2868-80.
37. Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg J. Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol. 1988;107:307-19.
38. Hedin U, Bottger BA, Luthman J, Johansson S, Thyberg J. A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. Dev Biol. 1989;133:489-501.
39. Schuger L, O'Shea KS, Nelson BB, Varani J. Organotypic arrangement of mouse embryonic lung cells on a basement membrane extract: Involvement of laminin. Development. 1990;110:1091-99.
40. Yamada KM. Fibronectins: Structure, function and receptors. Curr Opin in Cell Biol. 1989;1:956-63.
41. Harris P, Heath D. Causes of pulmonary arterial hypertension. In: Harris P, Heath D; eds. The Human Pulmonary Circulation. Edinburgh: Churchill Livingstone; 1986:226-38.
42. Meyrick B, Reid L. Pulmonary hypertension: Anatomic and physiologic correlates. In: Matthay R, Matthay M, Danztker R; eds. Clinics in Chest Medicine: Cardiovascular-Pulmonary Interactions in Normal and Diseased Lungs. Vol. 4. Philadelphia: W. B. Saunders Co.; 1983:199-217.
43. Cocks TM, Angus JA, Campbell JH, Campbell GR. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J Cell Physiol. 1985;123:310-20.
44. Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH. The nature of endothelium-derived vascular relaxant factor. Nature. 1984;308:645-47.
45. Johns RA, Linden JM, Peach MJ. Endothelium-dependent relaxation and cyclic GMP accumulation in rabbit pulmonary artery are selectively impaired by moderate hypoxia. Circ Res. 1989;65:1508-15.
46. Abraham AS, Kay JM, Cole RB, Pincock AC. Hemodynamic and pathological study of the effect of chronic hypoxia and subsequent recovery of the heart and pulmonary vasculature of the rat. Cardiovasc Res 1971;5:95-102.